Perioperative Decision-Making for a Solitary Fibrous Tumor of the Pleura: Lessons from Two Cases and Current Evidence

胸膜孤立性纤维瘤围手术期决策:两例病例的经验教训及最新证据

阅读:3

Abstract

Background and Clinical Significance: Solitary fibrous tumor of the pleura (SFTP), a rare mesenchymal neoplasm (<5% of pleural tumors), is often asymptomatic and incidentally detected. Preoperative differentiation between benign and malignant forms remains challenging, with 10-20% of lesions showing malignant behavior despite benign imaging. The role of conservative "watch-and-wait" versus early resection in small, asymptomatic cases is debated, prompting the need for structured perioperative decision-making based on imaging, pathology, and risk models. Case Presentation: We report two surgically resected SFTP cases. Case 1 involved an 8 cm giant pedunculated benign tumor managed by open thoracotomy (negative margins, mitotic count: 1.5-2.0/10 high-power fields, necrosis < 10%), with the patient remaining recurrence-free at 4 years postoperatively. Case 2 involved a 5.3 cm pedunculated benign tumor (initially 4.8 cm, which grew during a 2-year observation) excised via a minimally invasive technique (mitotic count: 0.5-1.5/10 high-power fields, necrosis < 10%), showing no recurrence over 6 months. In both cases, safe R0 resection was achieved through clinicoradiologic assessment and appropriate surgical technique selection. Both tumors were classified as benign and low risk by the England, Tapias, and modified Demicco models and are undergoing a tailored follow-up protocol. Conclusions: These two cases illustrate the feasibility of en bloc R0 resection in operable SFTP, despite interval growth observed in Case 2. Combined with literature evidence, early en bloc R0 resection appears to be preferable to prolonged observation for operable SFTP, balancing the risks of unpredictable growth, malignant transformation, and recurrence-even in histologically benign tumors (up to 6.3%)-against potential surgical morbidity. Tailored preoperative planning appears beneficial, complemented by pathology-based risk models for postoperative stratification and risk-adapted surveillance.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。